Regenerative Medicines Market size, Growth, Forecast 2021 JULY 2018

Regenerative Medicine Market by Therapy (Cell Therapy, Tissue Engineering, Immunotherapy,
Gene Therapy), Product (Cell-Based, Acellular), Applications (Orthopedic & Musculoskeletal
Disorders, Dermatology, Oncology, Cardiology) - Forecast to 2021
The Market Research on Regenerative Medicine, By Considering useful aspects like; Application,
End Users- Global Future Forecast till 2021, published by MarketsandMarkets™, the report
studies the global Regenerative Medicine market over the forecast period of 2017 to 2021. The
market is projected to reach USD 38.70 Billion by 2021 at a CAGR of 23.6%.
The global market is broadly classified into types, therapy, application and regions. Based on
types, the market is segmented into cell-based products and acellular products. The cell-based
products are expected to dominate the global market in 2018. Based on therapy, the market is
segmented into cell therapy, gene therapy, tissue engineering, and immunotherapy.
Immunotherapy is the fastest growing segment in the global market, during the forecast period.
The study estimates the Regenerative Medicine market size for 2018 and projects its demand
till 2021. In the primary research process, various sources from both demand side and supply
side were interviewed to obtain qualitative and quantitative information for the report. Primary
sources from the demand side include research scientists, Regenerative Medicine specialists,
laboratory technicians, and R&D professionals of pharmaceutical and biotechnology companies
and academic research institutes.
For the market estimation process, both top-down and bottom-up approaches were used to
estimate and validate the market size of the Regenerative Medicine market as well as to
estimate the market size of various other dependent submarkets. All possible parameters that
affect the market covered in this research study have been accounted for, viewed in extensive
detail, verified through primary research, and analyzed to get the final quantitative and
qualitative data.
The Regenerative Medicine market is fragmented with the presence of emerging players;
The key players in the cell-based products segment are Organogenesis Inc. (U.S.), Osiris
Therapeutics, Inc. (U.S.), Vericel Corporation (U.S.), Stryker Corporation (U.S.), and NuVasive,
Inc. (U.S.). The key players in the acellular products segment are Medtronic (Ireland), Acelity
(KCI Concepts) (U.S.), Integra LifeSciences (U.S.), Cook Biotech Inc. (U.S.), and C.R. Bard
(U.S)…..Read More
1